Corcept Therapeutics CORT 深 滬
已收盤 08-29 16:00:00 美东时间
69.72
+0.135
+0.19%
華盛通- 最 高69.88
- 今 開69.48
- 成交量 39.78万股
- 最 低 68.82
- 昨 收 69.585
- 總市值 73.21亿
- 52周最高 117.33
- 市盈率 靜 56.62
- 換手率 0.38%
- 52周最低 34.25
- 委 比 37.55%
- 總股本 1.05亿
- 歷史最高 117.33
- 量 比 0.55
- 振 幅 1.52%
- 歷史最低 1.27
- 每 手 1
- 風險率 12.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Corcept Therapeutics’ MOMENTUM Study: Assessing Hypercortisolism in Resistant Hypertension
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
08-08 00:29
A Look at Axsome Therapeutics's Upcoming Earnings Report
Axsome Therapeutics (NASDAQ:AXSM) is preparing to release its quarterly earning...
08-02 01:04
Piper Sandler Maintains Overweight on Corcept Therapeutics, Lowers Price Target to $121
Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:CORT) with a Overweight and lowers the price target from $131 to $121.
08-01 20:08
Earnings Scheduled For July 31, 2025
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
07-31 00:20
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 5 ...
07-21 22:30
What's Driving the Market Sentiment Around Corcept Therapeutics?
Corcept Therapeutics's (NYSE:CORT) short percent of float has fallen 9.51% sinc...
07-18 00:00
Corcept seeks FDA approval for ovarian cancer treatment
Corcept Therapeutics (NASDAQ:CORT) has submitted a marketing application to the U.S. FDA for its cortisol modulator, Relacorilant, a drug designed to help patients with ovarian cancer that does not re...
07-14 22:06
Here's How Much $100 Invested In Corcept Therapeutics 20 Years Ago Would Be Worth Today
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 20...
07-04 22:15
Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Resistant Hypertension
Corcept Therapeutics (($CORT)) announced an update on their ongoing clinical st...
06-27 00:25
